The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter study

The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter study - The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007294

Enrollment

100

Registered

2012-02-15

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGFR mutations in lung non-adeno and non small cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The cases of non-adeno and non-small cell lung cancer with EGFR-TKI treatment

Exclusion criteria

Exclusion criteria: The case that refused research participation.

Design outcomes

Primary

Measure	Time frame
Effectiveness of EGFR-TKI in non-adeno and non-small cell lung cancer	—

Countries

Japan

Contacts

Public ContactTaro Ohba

National Kyushu Cancer Center Department of Thoracic Oncology

ooba.t@nk-cc.go.jp092-541-3231

Outcome results